MMP9 rs3918242 has been associated with the risk of spontaneous deep intracerebral hemorrhage, potentially malignant and malignant lesions of the head and neck, and has served as a biological indicator of the efficacy of ulinastatin in the treatment of patients with severe acute pancreatitis [30,31,32]. This evidence concerns the gene MMP9 and acute pancreatitis.